Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.
Trifa AP, Bănescu C, Tevet M, Bojan A, Dima D, Urian L, Török-Vistai T, Popov VM, Zdrenghea M, Petrov L, Vasilache A, Murat M, Georgescu D, Popescu M, Pătrinoiu O, Balea M, Costache R, Coleș E, Șaguna C, Berbec N, Vlădăreanu AM, Mihăilă RG, Bumbea H, Cucuianu A, Popp RA. Trifa AP, et al. Br J Haematol. 2016 Jul;174(2):218-26. doi: 10.1111/bjh.14041. Epub 2016 Apr 7. Br J Haematol. 2016. PMID: 27061303 Free article.
Among a panel of polymorphisms in genes related to oxidative stress, CAT-262 C>T, GPX1 Pro198Leu and GSTP1 Ile105Val influence the risk of developing BCR-ABL negative myeloproliferative neoplasms.
Trifa AP, Bănescu C, Dima D, Bojan AS, Tevet M, Moldovan VG, Vesa ȘC, Murat M, Pop IV, Skrypnyk C, Popp RA. Trifa AP, et al. Among authors: bojan as. Hematology. 2016 Oct;21(9):520-5. doi: 10.1080/10245332.2016.1163889. Epub 2016 Mar 30. Hematology. 2016. PMID: 27077777
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients.
Trifa AP, Bănescu C, Bojan AS, Voina CM, Popa Ș, Vișan S, Ciubean AD, Tripon F, Dima D, Popov VM, Vesa ȘC, Andreescu M, Török-Vistai T, Mihăilă RG, Berbec N, Macarie I, Coliţă A, Iordache M, Cătană AC, Farcaș MF, Tomuleasa C, Vasile K, Truică C, Todincă A, Pop-Muntean L, Manolache R, Bumbea H, Vlădăreanu AM, Gaman M, Ciufu CM, Popp RA. Trifa AP, et al. Among authors: bojan as. Am J Hematol. 2018 Jan;93(1):100-106. doi: 10.1002/ajh.24946. Epub 2017 Nov 10. Am J Hematol. 2018. PMID: 29047144 Free article.
Modest contribution of JAK2 V617F allele burden to the occurrence of major thrombosis in polycthemia vera and essential thrombocythemia.
Trifa AP, Bănescu C, Voina CM, Popa Ș, Török-Vistai T, Bojan AS, Dima D, Zdrenghea M, Fetica B, Vișan S, Tomuleasa C, Pârvu A, Urian L, Pop B, Popov VM, Andreescu M, Popp RA. Trifa AP, et al. Among authors: bojan as. Blood Cells Mol Dis. 2018 Nov;73:45-46. doi: 10.1016/j.bcmd.2018.09.003. Epub 2018 Sep 20. Blood Cells Mol Dis. 2018. PMID: 30249383 No abstract available.
SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?
Turcas C, Moisoiu V, Stefancu A, Jurj A, Iancu SD, Teodorescu P, Pasca S, Bojan A, Trifa A, Iluta S, Zimta AA, Petrushev B, Zdrenghea M, Bumbea H, Coriu D, Dima D, Leopold N, Tomuleasa C. Turcas C, et al. Front Oncol. 2020 Jun 29;10:1024. doi: 10.3389/fonc.2020.01024. eCollection 2020. Front Oncol. 2020. PMID: 32695677 Free PMC article. Review.
TET2 rs1548483 SNP Associating with Susceptibility to Molecularly Annotated Polycythemia Vera and Primary Myelofibrosis.
Lighezan DL, Bojan AS, Iancu M, Pop RM, Gligor-Popa Ș, Tripon F, Cosma AS, Tomuleasa C, Dima D, Zdrenghea M, Fetica B, Ioniță I, Gaál IO, Vișan S, Mirea AM, Popp RA, Florea M, Araniciu C, Petrescu L, Pop IV, Bănescu C, Trifa AP. Lighezan DL, et al. Among authors: bojan as. J Pers Med. 2020 Dec 1;10(4):259. doi: 10.3390/jpm10040259. J Pers Med. 2020. PMID: 33271790 Free PMC article.
40 results